IP Verse

Medichem S.a. competitive analysis

Latest oppositions filed by Medichem S.a.

Explore patent oppositions filed by Medichem S.a. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
EP3251660
Apixaban FormulationsBRISTOL MYERS SQUIBB IRELANDJul 14, 2020
EP3257500
Apixaban FormulationsBRISTOL MYERS SQUIBB IRELANDJul 14, 2020
EP2099453
Combination Therapy Of Substituted OxazolidinonesBAYERJun 5, 2018
EP1674107
Use Of DaptomycinCUBIST PHARMACEUTICALSMay 23, 2017

Latest patents of Medichem S.a. opposed by its competitors

Explore Medichem S.a.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2499914
Dec 20, 2017Antiseptic Solutions Comprising Chlorhexidine Or Its Salt And An Anionic Dye And Their Preparation1
EP2470529
Nov 19, 2014A 1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol Derivative For Pharmaceutical Use, And The Use Of A 1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol Derivate With Substantially Undefined Crystal Shape For Preparing Said 1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol Derivative4

Latest PTAB cases involving Medichem S.a.

Discover the latest PTAB cases involving Medichem S.a., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Medichem S.a. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MEDICHEM S.A.45 - -
BRISTOL MYERS SQUIBB IRELAND - 47 - -
BRISTOL MYERS SQUIBB IRELAND UNLIMITED - 42 - -
PFIZER761174412